We recently sent letters to some patients about coverage changes to drugs they may be taking. Here are the changes for ConnectiCare members with:
- Medicare Advantage plans — We have removed Zytiga 250 MG tablet from our formulary and will no longer cover it. Please prescribe the preferred drug alternative of abiraterone acetate 250 mg tablet instead. This change was effective May 1, 2019.
- Commercial plans — After July 1, 2019, the following specialty drugs will only be covered if they are filled through Accredo Specialty Pharmacy, our exclusive specialty provider:
- Granix
- Leukine
- Neulasta
- Neupogen
- Zarxio
